Arne Freundt took over as Puma CEO effective immediately to replace Bjorn Gulden who relinquished the post to head rival Adidas.
Puma’s appointment of Freundt as chief executive with immediate effect on Tuesday came several weeks before it was initially announced.
Freundt, according to Puma, is receiving a four-year contract effective from January 1 of 2023. Gulden’s mandate as a Puma SE Management Board member expires at the end of 2022.
Héloïse Temple-Boyer, Chair of the Supervisory Board of Puma, called Freundt the ideal choice to continue Puma’s very successful path and to further accelerate the company’s momentum.
Freundt has held various positions for Puma for over ten years and was responsible for framing corporate strategy, taking care of the Global Direct-to-Consumer business, and the Region EMEA as a General Manager.
He has also been a member of the Management Board as Chief Commercial Officer since June 2021.


US Reviewing Visa Denial for Venezuelan Little League Team Barred from World Series
Venezuela Earthquake Death Toll Climbs to 3,811 as Government Seeks Sanctions Relief
US Seizes Nearly 400 Illegal World Cup Streaming Domains in Global Anti-Piracy Crackdown
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
Japan Wholesale Inflation Jumps as Energy Shock Drives Import Costs Higher
Marco Rubio Says U.S. Will Block IRGC-Linked Individuals From Iran World Cup Delegation
Trump Draws Cheers at Ryder Cup as U.S. Trails Europe After Opening Day
Oil Prices Rise as U.S.-Iran Conflict Fuels Strait of Hormuz Supply Fears
Apple Eyes U.S. Formula 1 Broadcast Rights in Major Sports Streaming Push
Cuba Power Outage Sparks Havana Protests as Fuel Crisis Deepens
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out
Fed Chair Kevin Warsh Launches Task Forces to Overhaul U.S. Monetary Policy Framework
China Inflation Cools in June as Producer Prices Hit Four-Year High
Gold Price Climbs Over 1% as Dollar Weakens, Fed Rate Debate and Iran Tensions Remain in Focus
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom
FBI Faces Historic Security Challenge Ahead of 2026 FIFA World Cup 



